You might like
Protestors at the Port of Oakland are trying to stop a ship that they say will carry weapons to Israel. bit.ly/3FItw7F
Your boss is a coward and it's killing your career. Here's the honest feedback you need to hear:
ChatGPT is everywhere and everyone is using it. But most academics don't know how to use it *smartly.* Here's how to use ChatGPT intelligently (and ethically) for academic purposes:
drug prices of FDA class of 2022, per Reuters launch drug prices, the next focus in the US?
U.S. new drug price exceeds $200,000 median in 2022 reut.rs/3Gn0xGo
Rounds 5 years back : VDT PACE, FLAG IDA, HAM,EPOCH, HyperCVAD Rounds today : Dara- RVD, Mylotarg, Inotuzumab,Blinatumumab, Aza- Ven, Ibrutinib- Ven. In the grind of daily rounds and clinic, there are moments of wonder to look over our shoulders and see how far we have come !
If you enjoy contemplating death on a Saturday, pls smash the RT button on the first tweet Stay rad, fam 🤙
How old will your kids be if you die at 85? Here are 4 bizarre insights that will make you want to work waaaay less:
Donald Pinkel, Developed a Cure for Childhood Leukemia, Dies at 95 nytimes.com/2022/03/12/hea… Developed “Total therapy for leukemia as the founding physician leader at @StJude and a strong supporter of desegregation and equity at a difficult time in this new hospital!
The U.S. has clearly turned the page on mask mandates, with many governors – even in blue states – removing mandates in most indoor spaces. apnews.com/article/corona… Soon, you’ll be allowed to go mask-less indoors. In this 🧵, I’ll address the harder question: should you? (1/25)
Pressure rises as Gilead awaits important study results for top cancer drug biopharmadive.com/news/gilead-tr… via @BioPharmaDive
Some folks are a bit confused about why things are likely to be much safer in a month than now – not why virus will peak & fall (we don’t entirely know) but why the risk to individuals will plummet – & with that, why activities that are unsafe now will be much safer then.(1/20🧵)
UCSF Grand Rounds: Eric Topol damns the ‘inevitability camp’ - Mission Local missionlocal.org/2022/01/ucsf-g…
Intimate portraits of a hospital COVID unit from a photojournalist-turned-nurse npr.org/sections/healt…
Considering Manufacturing and Commercial Advantages, Poseida Makes Strategic Shift Towards Allogeneic CAR-T Products - GeneOnline News geneonline.com/considering-ma…
geneonline.com
Considering Manufacturing and Commercial Advantages, Poseida Makes Strategic Shift Towards Alloge...
San Diego-based Poseida Therapeutics had always set its goal to move into allogeneic products. In its Q3 earnings announcement yesterday, the company officially announced its strategic shift to an...
Boom! It’s a new world for adults with relapsed/refractory B-ALL. Kite/Gilead recd approval today for Tecartus (Brexu-cel)! (With broadest possible indication in the PI. Wow.) Honored to play a small role to help pts with this dz as a ZUMA-3 site. #leusm fda.gov/drugs/resource…
Jon Rahm & @PGATOUR won't say, but seems pretty clear that Rahm wasn't vaccinated. A useful reminder that there's still plenty of Covid around & unvaxxed remain vulnerable. Very much hope he does well clinically. As for the tournament, he made a bet and lost, so zero sympathy.
Reminder this Sunday, June 6th, is National Cancer Survivors Day. #NCSD2021 #NCSD #NationalCancerSurvivorsDay ow.ly/Vlgi50EV6p5
Of 55 patients who received Tecartus for relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), 71% saw their signs of cancer disappear, Kite said at #ASCO21. endpts.com/asco21-a-week-…
endpoints.news
#ASCO21: A week after nabbing priority review, Kite unveils the pivotal data it hopes will lead to...
Just less than a year ago, Gilead’s Kite won a landmark okay for its second CAR-T therapy, with data that former head of global development Ken Takeshita hailed as ...
If the FDA approves Biogen’s Alzheimer’s treatment, I won’t prescribe it statnews.com/2021/05/30/if-… via @statnews
In case anyone cares, I've started eating indoors in SF restaurants. It wasn't any one thing; the risk just fell below my personal threshold: 2/3rds of SF adults fully vaxxed; avg 16 new cases/d in SF, asymptomatic test + @UCSF now 0.16% (ie, 1/600). Plus too cold to eat outside.
United States Trends
- 1. Broncos N/A
- 2. Jayda N/A
- 3. Jay Bilas N/A
- 4. Go Bills N/A
- 5. Odegaard N/A
- 6. Arteta N/A
- 7. Thomas Frank N/A
- 8. Slot N/A
- 9. Georgetown N/A
- 10. Merino N/A
- 11. Darnold N/A
- 12. Burnley N/A
- 13. Jasper Johnson N/A
- 14. Drew Lock N/A
- 15. Virginia N/A
- 16. #Caturday N/A
- 17. Liverpool N/A
- 18. Kolosov N/A
- 19. #Illini N/A
- 20. West Ham N/A
You might like
-
Nicola Polverelli, MD, PhD
@N_Polverelli -
Filippo A. Canale
@filcan87 -
Hien D. Liu, MD
@hiendliu1 -
Renata de Oliveira Costa
@DraRenataCosta -
anne mwirigi
@nkirote_77 -
Shashank Cingam
@Shashankcingam -
Luka Čemažar
@LukaCemazar -
Erica Lammerhirt Ottoni
@EricaLammerhirt -
Iram
@IramSaeed21 -
Hossein Sadrzadeh
@OncSadr
Something went wrong.
Something went wrong.